845PEVEROLIMUS FOR PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC) REFRACTORY TO ANTI-VEGF THERAPY: UPDATED RESULTS OF A POOLED ANALYSIS OF NONINTERVENTIONAL STUDIES von Sauvin, L. Albiges, Kube, U., Eymard, J., Schmidinger, M., Bamias, A., Kelkouli, N., Mraz, B., Florini, S., Rose, C., Cattaneo, A., Bergmann, L.

Volltext

Everolimus for Patients with Metastatic Renal Cell Carcinoma (Mrcc) Refractory to Anti-Vegf Therapy: Updated Results of a Pooled Analysis of Noninterventional Studies von Sauvin, L. Albiges, Kube, U., Eymard, J., Schmidinger, M., Bamias, A., Kelkouli, N., Mraz, B., Florini, S., Rose, C., Cattaneo, A., Bergmann, L.

Volltext

Prospective Observational Study on the Evaluation of Everolimus Adverse Events (Aes) in Metastatic Renal Cell Carcinoma (Mrcc) After First-Line Anti-Vegf Therapy. the French Afinit... von Lobbedez, F. Joly, Eymard, J., Sauvin, L. Albiges, Nguyen, T., Guillot, A., Rolland, F., Spaeth, D., Laguerre, B., Colin, P., Lebret, T., Slimane, K., Kelkouli, N., Ravaud, A.

Volltext

851PPROSPECTIVE OBSERVATIONAL STUDY ON THE EVALUATION OF EVEROLIMUS ADVERSE EVENTS (AES) IN METASTATIC RENAL CELL CARCINOMA (MRCC) AFTER FIRST-LINE ANTI-VEGF THERAPY. THE FRENCH AF... von Lobbedez, F. Joly, Eymard, J., Sauvin, L. Albiges, Nguyen, T., Guillot, A., Rolland, F., Spaeth, D., Laguerre, B., Colin, P., Lebret, T., Slimane, K., Kelkouli, N., Ravaud, A.

Volltext

Efficacy and safety of sequential use of everolimus in patients with metastatic renal cell carcinoma previously treated by bevacizumab with or without interferon therapy: Results f... von Thiery- Vuillemin, Antoine, Guillot, Aline, Steiner, Thomas, Herrmann, Edwin, Syrigos, Konstantinos N., Kelkouli, Nadia, Cattaneo, Agnese, Nguyen, Thierry

Volltext